Daqing People's Hospital

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Stroke3 trials
• Coronary artery disease2 trials
• High blood pressure2 trials
• Alzheimer disease1 trial
• Asthma1 trial
• Familial hypercholesterolaemia1 trial
• Heart failure1 trial
• Irritable bowel syndrome1 trial

Phase

• Phase 36 trials
• Phase 25 trials

Status

• Completed7 trials
• Not yet recruiting3 trials
• Recruiting1 trial

Lead sponsor

• Bayer1 trial
• Beijing Inno Medicine Co., Ltd.1 trial
• Beijing Tiantan Hospital1 trial
• Capital Medical University1 trial
• Lei Yunshang Group1 trial
• and 6 more

Running trials

• Not yet recruiting

  A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension

  NCT07833098· Phase 2· Zhejiang Yangli Pharmaceutical Technology Co., Ltd.· Source

  Contact: Xianyou Ji

• Recruiting

  Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

  NCT07687186· Phase 3· Tasly Pharmaceutical Group Co., Ltd· Source

  Contact: Xianyou Ji

• Not yet recruiting

  Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)

  NCT07721012· Phase 2· Lei Yunshang Group· Source

  Contact: Yayun Zhang

• Recruiting

  A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  NCT07521007· Phase 2· Beijing Inno Medicine Co., Ltd.· Source

  Contact: Shu Zhang

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease2 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Irritable bowel syndrome1 recruiting

Closed trials

• Completed

  Budesonide/Formoterol Inhalation Powder in Adults With Asthma

  NCT07790159· Phase 3· Shanghai Xin Huanghe Pharmaceutical Co., Ltd.· Source

• Completed

  Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

  NCT06429384· Phase 2· Beijing Tiantan Hospital· Source

• Completed

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· Phase 3· Tasly Biopharmaceuticals Co., Ltd.· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Bayer· Source

• Completed

  To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil

  NCT06500689· Phase 3· Shenzhen Salubris Pharmaceuticals Co., Ltd.· Source

• Completed

  Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

  NCT05142722· Phase 3· NewAmsterdam Pharma· Source

• Completed

  Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease

  NCT05269173· Phase 2· Capital Medical University· Source